Advanced Lipid Nanosystems for Nutraceuticals with Sphingomyelin & Vitamin E

DIVERSA Technologies develops proprietary lipid nanosystems systems uniquely formulated with sphingomyelin and vitamin E, specifically tailored to enhance the performance of nutraceutical products. Our advanced lipid nanosystems significantly improve the solubility, stability, and bioavailability of natural actives, ensuring superior absorption and efficacy.

Sphingomyelin, a natural lipid found in cell membranes, enhances biocompatibility and promotes better integration with biological tissues, supporting efficient nutrient uptake. Vitamin E acts as a powerful antioxidant, protecting both the encapsulated compound and the consumer against oxidative stress, while also improving the shelf life of sensitive ingredients.

Our technology achieves >90% encapsulation efficiency, demonstrates up to 28X higher in vitro and 567X higher in vivo delivery efficiency, and can extend active half-life by over 26-fold, enabling sustained release and longer-lasting physiological effects.

Key benefits for nutraceuticals include:

• Enhanced bioavailability: Maximizes absorption of poorly soluble natural compounds.

• Stability: Protects sensitive actives from degradation, extending shelf life and potency.

• Antioxidant synergy: Vitamin E protects the payload and supports health benefits.

• Biocompatibility: Sphingomyelin facilitates safe, effective delivery with minimal irritation.

• PEG-free options: Meet clean-label demands and regulatory requirements.

• Versatile: Suitable for botanicals, polyphenols, peptides, vitamins, and more.

• Scalable: Seamlessly moves from lab-scale development to commercial production.

By integrating patented nanotechnology with bioactive lipids, DIVERSA provides nutraceutical companies a distinctive platform to formulate next-generation products with proven advantages, all backed by strong IP protection and freedom-to-operate (FTO).